5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.97▼ | 3.00▼ | 3.00▼ | 3.14▼ | 3.16▼ |
MA10 | 3.01▼ | 3.03▼ | 3.05▼ | 3.33▼ | 2.84▲ |
MA20 | 3.08▼ | 3.16▼ | 3.18▼ | 3.12▼ | 2.29▲ |
MA50 | 3.26▼ | 3.27▼ | 3.36▼ | 2.67▲ | 2.03▲ |
MA100 | 3.40▼ | 3.26▼ | 3.14▼ | 2.19▲ | 2.06▲ |
MA200 | 3.19▼ | 3.07▼ | 2.91▲ | 2.07▲ | 2.72▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.006▼ | -0.016▼ | -0.024▼ | -0.066▼ | 0.120▲ |
RSI | 30.606▼ | 31.529▼ | 33.344▼ | 48.209▼ | 57.380▲ |
STOCH | 11.965▼ | 13.006▼ | 10.697▼ | 20.208 | 60.389 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -81.935▼ | -47.214 |
CCI | -126.615▼ | -111.459▼ | -107.523▼ | -84.356 | 64.973 |
▼ GAP | $AKTX Open Gap Down %2 | Set Alert |
Tuesday, March 02, 2021 05:22 PM
Akari Therapeutics, Plc (NASDAQ:AKTX) was the recipient of a large decline in short interest in the month of February. As of February 12th, there was short interest totalling 35,300 shares, a decline ...
|
Friday, February 26, 2021 01:00 PM
After several positive clinical updates, shares of the rare-disease-focused biotech fell. Is this simply a matter of traders looking to book a profit from this red hot stock?
|
Thursday, February 25, 2021 02:11 PM
In a non-infectious allergic uveitis animal model, PAS-nomacopan reduced VEGF by more than 50% compared to saline control, equivalent to the inhibition caused by an anti-VEGF antibody. Separately ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
04/03/21 | 2.94 | 3.05 | 2.94 | 2.94 | 178,887 |
03/03/21 | 3.09 | 3.1247 | 2.95 | 2.95 | 115,854 |
02/03/21 | 3.33 | 3.33 | 3.0401 | 3.11 | 118,902 |
01/03/21 | 3.45 | 3.45 | 3.28 | 3.34 | 78,391 |
26/02/21 | 3.25 | 3.35 | 3.04 | 3.35 | 123,075 |
25/02/21 | 3.54 | 3.60 | 3.2935 | 3.32 | 228,859 |
24/02/21 | 3.20 | 3.55 | 3.20 | 3.46 | 140,097 |
23/02/21 | 3.58 | 3.58 | 3.10 | 3.20 | 253,317 |
22/02/21 | 4.085 | 4.21 | 3.61 | 3.73 | 481,241 |
19/02/21 | 3.37 | 3.90 | 3.36 | 3.88 | 577,924 |
|
|
||||
|
|
||||
|
|